Choose language:
Keyword:
About us
Products
Manufacturing
Investor Relations
Press
Company Announcements
Press Releases
Publications
Photos
Stock shots
Contact
Join Us
Press Releases
10 April 2008
Post-exposure vaccination with IMVAMUNE® protects against lethal poxvirus infection
11 July 2007
Bavarian Nordic Granted another European Patent on MVA
10 April 2007
Canadian government issues RFP for the acquisition of an MVA-based smallpox vaccine
12 June 2006
Danish Prime Minister Fogh Rasmussen Visits Bavarian Nordic in the USA
5 May 2006
Bavarian Nordic Strengthens Investor Relations Function
8 March 2006
Bavarian Nordic Able to Manufacture Influenza Vaccines
4 October 2005
Bavarian Nordic Confirms Proposal Submitted to Supply IMVAMUNE™ Smallpox Vaccine to US Government
28 September 2005
NNE builds new vaccine facility for Bavarian Nordic in record time
6 July 2005
Bavarian Nordic A/S and Oxxon Therapeutics Cross-license MVA and PrimeBoost Patents
8 June 2005
Bavarian Nordic announces result of efficacy study
24 February 2005
Bavarian Nordic Provides Update on Business and Development Activities - All Programmes On-track
1 September 2004
Bavarian Nordic receives regional environmental approval of Kvistgård facility
Home
|
Sitemap
|
Disclaimer
|
Privacy
Contact us
